Controversies As testicular malignancy is a disease of young population with good long term prognosis and multidisciplinary treatment is evolving to reduce morbidity, certain areas of controversies have evolved.
• Postchemotherapy Residual Disease: postchemotherapy retroperitoneal masses are found to be teratoma or viable GCT in 45% of CT radiographic masses of 11-20 mm and 28% of the 0-10 mm [44]. Ehrlich found 15-year recurrence-free survival rates of 95% and 73% for good risk and intermediate-risk or poor-risk patients, respectively; who were kept on survelliance after chemotherapy and radiographic complete response (residual mass 40 had significant association with identifying positive lymph nodes. Study on postchemotherapy RPLND reported
• Postchemotherapy Residual Disease: postchemotherapy retroperitoneal masses are found to be teratoma or viable GCT in 45% of CT radiographic masses of 11-20 mm and 28% of the 0-10 mm [44]. Ehrlich found 15-year recurrence-free survival rates of 95% and 73% for good risk and intermediate-risk or poor-risk patients, respectively; who were kept on survelliance after chemotherapy and radiographic complete response (residual mass 40 had significant association with identifying positive lymph nodes. Study on postchemotherapy RPLND reported